Back to News
Market Impact: 0.3
Personalis, Inc. Reports Q3 Clinical Test Volume of 13,157 and Overall Revenue of $25.6 million
Source: Nasdaq
Corporate EarningsHealthcare & BiotechCompany Fundamentals
Personalis reported Q3 2026 revenue of $25.6 million, up from $14.5 million in Q3 2025, an increase of approximately 76%. The company attributed the growth primarily to clinical test revenue, which reached $4.4 million; the provided article excerpt does not include a comparison for that figure or further results.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
PSNL0.60
More News
- Tech stocks are suffering their biggest selloff since Covid, as investors see premature end to AI datacenter boom
- Elon Musk's Tesla and SpaceX lose over $420 billion in combined market cap after midterms
- We're raising our price target on Cardinal Health after another stellar quarter of profits
- Costco is taking aim at its May record high — how it got here and where's it going
- Neocloud IREN says $4 billion in annualized revenue being delayed due to customer request
- Tapestry CEO on Earnings Beat, Consumer Outlook